Cargando…

Sodium‐glucose transporter 2 inhibitors may improve the prognosis of acute heart failure by correcting hypocapnia

Detalles Bibliográficos
Autores principales:	Tang, Wen‐Jing, Yu, Miao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Reply
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10192284/ https://www.ncbi.nlm.nih.gov/pubmed/37072017 http://dx.doi.org/10.1002/ehf2.14388

Ejemplares similares

Hypocapnia is an independent predictor of in‐hospital mortality in acute heart failure
por: Tang, Wen‐Jing, et al.
Publicado: (2023)

Clinical determinants and prognostic significance of hypocapnia in acute heart failure
por: Garus, Mateusz, et al.
Publicado: (2022)

Letter regarding the article “Hypocapnia is an independent predictor of in‐hospital mortality in acute heart failure”
por: Guarnaccia, Alberto, et al.
Publicado: (2023)

Correction: Sodium-glucose co-transporter 2 inhibitor therapy: mechanisms of action in heart failure
Publicado: (2021)

Response to Letter to the editor regarding ‘Discordance between estimated and measured changes in plasma volume among patients with acute heart failure’
por: Swolinsky, Jutta S., et al.
Publicado: (2022)

The Evolution of Sodium-Glucose Co-Transporter-2 Inhibitors in Heart Failure
por: Fadiran, Olusayo, et al.
Publicado: (2021)

Response to Latest British Society of Echocardiography recommendations for left ventricular ejection fraction categorisation: potential implications and relevance to contemporary heart failure management
por: Harkness, Allan, et al.
Publicado: (2020)

Mechanisms and Perspectives of Sodium-Glucose Co-transporter 2 Inhibitors in Heart Failure
por: Zeng, Qingchun, et al.
Publicado: (2021)

Sodium‑glucose co-transporter‑2 inhibitors in the treatment of diabetes with heart failure
por: Liang, Bo, et al.
Publicado: (2022)

Conditioning on a Collider May or May Not Explain the Relationship Between Lower Neuroticism and Premature Mortality in the Study by Gale et al. (2017): A Reply to Richardson, Davey Smith, and Munafò (2019)
por: Weiss, Alexander, et al.
Publicado: (2019)

Association of Hypocapnia in Children with Febrile Seizures
por: Sachan, Deepak, et al.
Publicado: (2018)

The Effects of Hypocapnia on Brain Tissue Pulsations
por: Alharbi, Meshal, et al.
Publicado: (2020)

Reply to comment on: Urinary sodium excretion and its association with blood pressure in Nigeria: A nationwide population survey
por: Odili, Augustine N., et al.
Publicado: (2021)

Heart Rate Recovery Is Impaired in Patients with Psoriasis
por: Sarli, Bahadir, et al.
Publicado: (2014)

Sodium-glucose co-transporter 2 inhibitor therapy: mechanisms of action in heart failure
por: Joshi, Shruti S, et al.
Publicado: (2021)

Eligibility of outpatients with chronic heart failure for sodium–glucose co‐transporter‐2 inhibitors
por: Angelini, Gianmarco, et al.
Publicado: (2021)

Which is the correct answer to the Mpemba puzzle?
por: Romanovsky, Andrej A
Publicado: (2015)

Three Doses of Hepatitis B Vaccine or Four Doses in Chronic Renal Failure
por: Khazaeipour, Zahra, et al.
Publicado: (2013)

Correction to Figures: A Reply to Hwang and Peli (2014)
por: Gao, Zhongpai
Publicado: (2017)

Response to the Article on Antibiotics and Immune Checkpoint Inhibitors by Lin et al.
por: Cheung, Ka Shing, et al.
Publicado: (2022)

What Makes Sodium-Glucose Co-Transporter-2 Inhibitors Stand out in Heart Failure?
por: Khan, Muhammad Shahzeb, et al.
Publicado: (2020)

Sodium–Glucose Co-transporter 2 Inhibitors in Heart Failure: Recent Data and Implications for Practice
por: Rosano, Giuseppe, et al.
Publicado: (2020)

Robustness of outcomes in trials evaluating sodium–glucose co‐transporter 2 inhibitors for heart failure
por: Usman, Muhammad Shariq, et al.
Publicado: (2022)

Sodium-glucose Co-transporter 2 Inhibitors: a New Path for Heart Failure Treatment
por: Oh, Jaewon, et al.
Publicado: (2021)

Sodium-Glucose Co-Transporter 2 Inhibitors in Heart Failure—Current Evidence in Special Populations
por: Moady, Gassan, et al.
Publicado: (2023)

Reply to the Comment on: Marco Cirillo The Memory of the Heart. J. Cardiovasc. Dev. Dis. 2018, 5, 55
por: Cirillo, Marco
Publicado: (2018)

Reply to: “Vitamin D Insufficiency May Account for Almost Nine of Ten COVID-19 Deaths: Time to Act. Comment on: Vitamin D Deficiency and Outcome of COVID-19 Patients. Nutrients 2020, 12, 2757”
por: Radujkovic, Aleksandar, et al.
Publicado: (2020)

Comment on “Renail failure suppresses muscle irisin expression, and irisin blunts cortical bone loss in mice” by Kawao et al. ‐ the authors' reply
por: Kawao, Naoyuki, et al.
Publicado: (2022)

Association Between Periprocedural Heart Rate Trend and Postprocedural Worsening Heart Failure in Patients Receiving Catheter Ablation for Atrial Fibrillation　― Reply ―
por: Matsuda, Yasuhiro, et al.
Publicado: (2022)

Reply to Veerman et al. Comment on “Rosenzweig et al. Very Low Prostate PET/CT PSMA Uptake May Be Misleading in Staging Radical Prostatectomy Candidates. J. Pers. Med. 2022, 12, 410”
por: Rosenzweig, Barak, et al.
Publicado: (2022)

Antibiotics Associated with Lower Survival in Hepatocellular Cancer Patients Receiving Immune Checkpoint Inhibitors Independent of Tumor Status
por: Cheung, Ka Shing, et al.
Publicado: (2022)

Sodium-glucose cotransporter 2 inhibitor may not prevent atrial fibrillation in patients with heart failure: a systematic review
por: Ouyang, Xiaolan, et al.
Publicado: (2023)

Reply to Mahat, R.K.; Rathore, V. Comment on “Xiang et al. Association between the Triglyceride-Glucose Index and Vitamin D Status in Type 2 Diabetes Mellitus. Nutrients 2023, 15, 639”
por: Xiang, Qunyan, et al.
Publicado: (2023)

Effect of Empagliflozin in Preventing Progression of Renal Dysfunction in Diabetic Patients With Compensated Heart Failure　― Reply ―
por: Shirakabe, Akihiro, et al.
Publicado: (2021)

Reply to Comments: Using the Cardio-Ankle Vascular Index (CAVI) or the Mathematical Correction Form (CAVI(0)) in Clinical Practice
por: Spronck, Bart, et al.
Publicado: (2020)

Significance of Hypocapnia in the Risk Assessment of Patients with Pulmonary Hypertension
por: Aetou, Maria, et al.
Publicado: (2023)

Reply: “Comment on: Chocolate Consumption and Risk of Coronary Heart Disease, Stroke, and Diabetes: A Meta-Analysis of Prospective Studies, Nutrients 2017, 9, 688”
por: Yuan, Sheng, et al.
Publicado: (2017)

Response to Comment on Giuseppe Genchi et al. Mercury Exposure and Heart Diseases. Int. J. Environ. Res. Public Health 2017, 14, 74
por: Genchi, Giuseppe, et al.
Publicado: (2017)

Reply to Siniorakis et al., “COVID-19 Interference with Renin-Angiotensin System in the Context of Heart Failure”
por: Fedson, David S., et al.
Publicado: (2020)

Reply to Foster, K.R.; Balzano, Q. Comment on “Redmayne, M.; Maisch, D.R. ICNIRP Guidelines’ Exposure Assessment Method for 5G Millimetre Wave Radiation May Trigger Adverse Effects. Int. J. Environ. Res. Public Health 2023, 20, 5267”
por: Redmayne, Mary, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_c7gr5l5f3bu10ptd5n643i7t3f